Cocooning (immunization) Cocooning (immunization) Cocooning, also known as the Cocoon Strategy, is a vaccination strategy that has been recommended by the Centers for Disease Control and Prevention (CDC) in the United States since 2006. It aims to protect newborn infants from becoming infected with pertussis by administering DTaP/Tdap (tetanus, diphtheria and acellular pertussis) booster vaccine to mothers, family members and any individuals who would come into regular contact with the newborn infant. By vaccinating these individuals with a pertussis booster a pool of persons is established around the newborn who are themselves protected from getting pertussis and passing it on to the
Tay–Sachs disease Researchers are looking at gene therapy or enzyme replacement therapy as possible treatments. Tay–Sachs disease is typically first noticed in infants around 6 months old displaying an abnormally strong response to sudden noises or other stimuli, known as the "startle response". There may also be listlessness or muscle stiffness (hypertonia). The disease is classified into several forms, which are differentiated based on the onset age of neurological symptoms. Until the 1970s and 1980s, when the disease's molecular genetics became known, the juvenile and adult forms of the disease were not always recognized as variants of Tay–Sachs disease. Post-infantile Tay–Sachs was